InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation
NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical...
Riyadh International Philosophy Conference 2024 Concludes with a Focus on Quality of Life
Day 3 explored the philosophical contributions to the quality of life, and the ethical implications of AI and its impact on human life RIYADH, Saudi Arabia, Dec. 8, 2024 /PRNewswire/ -- The Riyadh International Philosophy Conference 2024 concluded...
Riyadh International Philosophy Conference 2024: A Captivating Opening Day Focused on Quality of Life
Over 60 Renowned Thinkers Gather to Explore "Philosophy and Quality of Life: Existence, Truth, and Goodness" RIYADH, Saudi Arabia, Dec. 6, 2024 /PRNewswire/ -- The Riyadh International Philosophy Conference 2024 launched its fourth and largest...
Riyadh International Philosophy Conference 2024: Bigger and bolder in its fourth edition
Over 60 renowned philosophers and thinkers to join Riyadh's leading intellectual platform to explore "Philosophy and Quality of Life: Existence, Truth, and Goodness" RIYADH, Saudi Arabia, Dec. 3, 2024 /PRNewswire/ -- The Riyadh International...